Q2 2023 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2023-08-14 · accession 0001387131-23-009765
$286.8M
Reported value
71
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $21.4M | 7.45% | 92,500 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $17.5M | 6.10% | 550,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $14.5M | 5.06% | 211,608 | Common | SOLE |
| 16961L106 | — | CHINOOK THERAPEUTICS INC | $12.3M | 4.30% | 321,017 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $12.3M | 4.28% | 53,100 | CALL | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $12.0M | 4.20% | 1,600,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $11.6M | 4.04% | 201,887 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $11.5M | 4.01% | 1,050,118 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $11.4M | 3.97% | 40,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $9.6M | 3.36% | 910,317 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $9.5M | 3.30% | 447,667 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $9.5M | 3.30% | 12,000,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $7.2M | 2.49% | 226,275 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $6.8M | 2.38% | 100,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.5M | 2.25% | 376,000 | PUT | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.7M | 1.98% | 350,000 | PUT | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $5.6M | 1.94% | 900,723 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $5.4M | 1.89% | 650,875 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A S | $5.2M | 1.80% | 57,760 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $4.9M | 1.72% | 260,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.9M | 1.70% | 300,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $4.3M | 1.50% | 60,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $4.2M | 1.46% | 751,796 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.1M | 1.42% | 125,148 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $3.8M | 1.32% | 1,589,017 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $3.5M | 1.21% | 300,000 | Common | SOLE |
| 29664WAB1 | ESPR 4 11/15/25 | ESPERION THERAPEUTICS INC NE | $3.4M | 1.20% | 6,925,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.4M | 1.19% | 130,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $3.3M | 1.15% | 100,696 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $3.1M | 1.08% | 130,400 | CALL | SOLE |
| 75615P103 | — | REATA PHARMACEUTICALS INC | $3.0M | 1.03% | 29,105 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $3.0M | 1.03% | 87,031 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $2.7M | 0.93% | 983,300 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $2.7M | 0.93% | 983,300 | PUT | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.3M | 0.81% | 60,376 | Common | SOLE |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $2.2M | 0.78% | 240,244 | Common | SOLE |
| 00773J103 | — | AEGLEA BIOTHERAPEUTICS INC | $2.2M | 0.77% | 4,900,000 | Common | SOLE |
| 92731L106 | — | VINCERX PHARMA INC | $1.9M | 0.68% | 1,492,771 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $1.8M | 0.64% | 800,676 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.6M | 0.56% | 125,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.6M | 0.56% | 178,292 | Common | SOLE |
| 46122TAA0 | — | PRECIGEN INC | $1.5M | 0.53% | 1,500,000 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $1.3M | 0.45% | 600,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $1.3M | 0.45% | 187,675 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $1.3M | 0.44% | 150,000 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $1.2M | 0.43% | 118,891 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.2M | 0.41% | 100,000 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $1.1M | 0.38% | 861,200 | PUT | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.1M | 0.37% | 240,200 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.1M | 0.37% | 62,500 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $999,000 | 0.35% | 100,000 | Common | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $975,000 | 0.34% | 325,000 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $918,000 | 0.32% | 340,000 | CALL | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $911,000 | 0.32% | 10,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $898,250 | 0.31% | 12,500 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $855,194 | 0.30% | 300,068 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $776,100 | 0.27% | 30,000 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $714,292 | 0.25% | 202,349 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $695,315 | 0.24% | 13,923 | Common | SOLE |
| 471871103 | — | JASPER THERAPEUTICS INC | $653,419 | 0.23% | 476,948 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $632,750 | 0.22% | 187,204 | Common | SOLE |
| 87410C104 | — | TALARIS THERAPEUTICS INC | $608,000 | 0.21% | 200,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $604,288 | 0.21% | 35,133 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $490,600 | 0.17% | 20,000 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $488,256 | 0.17% | 18,087 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $450,000 | 0.16% | 250,000 | Common | SOLE |
| H57830103 | — | NLS PHARMACEUTICS LTD | $440,000 | 0.15% | 400,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $428,118 | 0.15% | 267,574 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $77,330 | 0.03% | 37,000 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $42,336 | 0.01% | 33,600 | CALL | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $13,913 | 0.00% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.